WallStreetZenWallStreetZen

NYSE: ELV
Elevance Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ELV

Based on 13 analysts offering 12 month price targets for Elevance Health Inc.
Min Forecast
$500.00+1.52%
Avg Forecast
$564.54+14.62%
Max Forecast
$625.00+26.9%

Should I buy or sell ELV stock?

Based on 13 analysts offering ratings for Elevance Health Inc.
Strong Buy
Strong Buy
7 analysts 53.85%
Buy
4 analysts 30.77%
Hold
2 analysts 15.38%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ELV stock forecasts and price targets.

ELV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
RBC Capital
Top 27%
74
HoldMaintains$523.00+6.19%2023-01-26
SVB Leerink
Top 20%
81
BuyReiterates$580.00+17.76%2023-01-26
Wells Fargo
Bottom 8%
8
Strong BuyMaintains$609.00+23.65%2023-01-04
Mizuho
Top 12%
89
Strong BuyMaintains$575.00+16.74%2022-11-10
Deutsche Bank
Top 14%
87
Strong BuyMaintains$581.00+17.96%2022-10-21Find out why
Morgan Stanley
Top 3%
98
HoldMaintains$500.00+1.52%2022-10-21
Bank of America
Bottom 6%
6
Strong BuyUpgrades$575.00+16.74%2022-09-09
Loop Capital
Top 15%
86
Strong BuyInitiates Coverage On$550.00+11.67%2022-06-17
Bernstein
Bottom 27%
27
BuyReinstates$596.00+21.01%2022-05-27
BMO Capital
Top 14%
87
BuyMaintains$625.00+26.90%2022-04-25

1 of 2

Forecast return on equity

Is ELV forecast to generate an efficient return?
Company
N/A
Industry
29.68%
Market
12.46%

Forecast return on assets

Is ELV forecast to generate an efficient return on assets?
Company
N/A
Industry
9.11%

ELV earnings per share forecast

What is ELV's earnings per share in the next 3 years based on estimates from 18 analysts?
Avg 1 year Forecast
$32.43+25.65%
Avg 2 year Forecast
$36.94+43.12%
Avg 3 year Forecast
$42.74+65.59%
ELV's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ELV revenue forecast

What is ELV's revenue in the next 3 years based on estimates from 17 analysts?
Avg 1 year Forecast
$163.6B+6.79%
Avg 2 year Forecast
$175.6B+14.58%
Avg 3 year Forecast
$199.6B+30.27%
ELV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ELV earnings growth forecast

How is ELV forecast to perform vs Healthcare Plans companies and vs the US market?
Company
17.82%
Industry
15.65%
Market
24.23%
ELV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ELV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ELV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ELV revenue growth forecast

How is ELV forecast to perform vs Healthcare Plans companies and vs the US market?
Company
8.43%
Industry
8.84%
Market
9.31%
ELV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ELV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ELV vs Healthcare Plan Stocks

TickerPricePrice TargetUp/downsideConsensus
ELV$492.53$564.54+14.62%Strong Buy
CVS$87.78$116.56+32.79%Strong Buy
CI$308.30$315.64+2.38%Buy
HUM$481.69$585.20+21.49%Strong Buy
CNC$75.25$99.23+31.87%Strong Buy
View Top Healthcare Plan Stocks

Elevance Health Stock Forecast FAQ

Is Elevance Health Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NYSE: ELV) stock is to Strong Buy ELV stock.

Out of 13 analysts, 7 (53.85%) are recommending ELV as a Strong Buy, 4 (30.77%) are recommending ELV as a Buy, 2 (15.38%) are recommending ELV as a Hold, 0 (0%) are recommending ELV as a Sell, and 0 (0%) are recommending ELV as a Strong Sell.

If you're new to stock investing, here's how to buy Elevance Health stock.

What is ELV's earnings growth forecast for 2023-2025?

(NYSE: ELV) Elevance Health's forecast annual earnings growth rate of 17.82% is forecast to beat the US Healthcare Plans industry's average forecast earnings growth rate of 15.65%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 24.23%.

Elevance Health's earnings in 2023 is $6,213,000,000.On average, 18 Wall Street analysts forecast ELV's earnings for 2023 to be $7,745,178,484, with the lowest ELV earnings forecast at $7,644,870,900, and the highest ELV earnings forecast at $7,857,427,448. On average, 13 Wall Street analysts forecast ELV's earnings for 2024 to be $8,822,290,879, with the lowest ELV earnings forecast at $8,638,393,641, and the highest ELV earnings forecast at $9,149,484,666.

In 2025, ELV is forecast to generate $10,207,490,855 in earnings, with the lowest earnings forecast at $9,741,777,070 and the highest earnings forecast at $10,869,043,257.

What is ELV's revenue growth forecast for 2023-2025?

(NYSE: ELV) Elevance Health's forecast annual revenue growth rate of 8.43% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 8.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.31%.

Elevance Health's revenue in 2023 is $153,247,000,000.On average, 17 Wall Street analysts forecast ELV's revenue for 2023 to be $39,083,773,881,134, with the lowest ELV revenue forecast at $37,643,239,226,578, and the highest ELV revenue forecast at $42,700,281,920,258. On average, 13 Wall Street analysts forecast ELV's revenue for 2024 to be $41,937,539,226,934, with the lowest ELV revenue forecast at $39,635,085,143,216, and the highest ELV revenue forecast at $48,731,072,431,268.

In 2025, ELV is forecast to generate $47,679,247,100,830 in revenue, with the lowest revenue forecast at $42,960,257,684,644 and the highest revenue forecast at $56,463,354,226,100.

What is ELV's forecast return on assets (ROA) for 2023-2026?

(NYSE: ELV) forecast ROA is N/A, which is lower than the forecast US Healthcare Plans industry average of 9.11%.

What is ELV's Price Target?

According to 13 Wall Street analysts that have issued a 1 year ELV price target, the average ELV price target is $564.54, with the highest ELV stock price forecast at $625.00 and the lowest ELV stock price forecast at $500.00.

On average, Wall Street analysts predict that Elevance Health's share price could reach $564.54 by Jan 26, 2024. The average Elevance Health stock price prediction forecasts a potential upside of 14.62% from the current ELV share price of $492.53.

What is ELV's Earnings Per Share (EPS) forecast for 2023-2025?

(NYSE: ELV) Elevance Health's current Earnings Per Share (EPS) is $25.81. On average, analysts forecast that ELV's EPS will be $32.43 for 2023, with the lowest EPS forecast at $32.01, and the highest EPS forecast at $32.90. On average, analysts forecast that ELV's EPS will be $36.94 for 2024, with the lowest EPS forecast at $36.17, and the highest EPS forecast at $38.31. In 2025, ELV's EPS is forecast to hit $42.74 (min: $40.79, max: $45.51).

What is ELV's forecast return on equity (ROE) for 2023-2026?

(NYSE: ELV) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.